1 Min Read
April 20 (Reuters) - Cellnovo Group SA
* Announces that Diabeloop is launching a CE marking registration study on artificial pancreas with Cellnovo pump Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.